Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study

Clinical trial NCT05713851 · UNKNOWN

Trial details

NCT number: NCT05713851
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

AKI - Acute Kidney Injury Biomarkers Transition to CKD CKD

Start date: 2023-01-01
Primary completion: 2024-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.